Global Polysomnography (PSG) Device Market Research Report
- Report Code: HE 1132
- Publish Date: Upcoming
The global Polysomnography (PSG) device market, mainly driven by an enormous patient base suffering from Obstructive Sleep Apnea (OSA) accompanied by the technological amelioration of well-designed Clinical and Ambulatory PSG device worldwide, was valued at $2.2 billion in 2013 and is expected to reach $4.4 billion in 2018, growing at a CAGR of 14.7% between 2013 and 2018.
The report on the global PSG device market analyzes the market under two segments: clinical and ambulatory polysomnography devices. All these segments will see substantial growth owing to the elevated momentum in awareness levels among caregivers and patients. The clinical PSG device segment is the largest and has been contributing majorly—around 58% in terms of value—towards the total PSG device industry. In terms of volume (units), ambulatory PSG devices contribute a larger share towards the market. Both markets have been witnessing maximum growth because of an increase in patient pool and rise in incidence of OSA.
North America accounted for the largest market share in 2012, followed by Europe. This is chiefly attributed to the increasing healthcare awareness of sleep apnea, rising disposable incomes, improving healthcare infrastructure, economic growth favored by broadening insurance coverage, and increasing obesity, adding to the pool of sleep apnea patients. According to The European Sleep Apnea Database (ESADA), by March 2014, enrolled patients reached 15,956 along with 5313 follow-up visits. Furthermore, according to the National Sleep Foundation, in 2012, around 40 million Americans were reported to suffer from chronic sleep disorders.
The PSG device market in Asia has been experiencing a relatively low growth due to lack of awareness of the disease, low insurance coverage, and large number of undiagnosed cases.
The report on the global PSG device market provides a detailed competitive landscape of companies operating in this market. The main companies operating in the market are Natus Medical Incorporated, Compumedics Ltd., Philips Respironics, and other companies. Segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of major companies have been detailed in the report.
Report Customization Options
Along with market data, you can also customize MMM offerings that are in keeping with your company’s specific needs. Customize your report on the global market for PAP devices to get an insight into all-inclusive industry standards and a deep-dive analysis of the following considerations:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of the product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence of OSA
- Country-specific patient pool of OSA
- Disease progression (pattern analysis)
Macro Indicators
- Healthcare expenditure across major geographies
- Number of hospitals, number of diagnostic clinics, and home healthcare units
Ancillary Data
- Number of unit sales along with the respective ASPs annually in each country tracked till sub-segment level
- Usage data and purchasing data
Surgeon/Physician Perception Analysis
- Fast turnaround analysis of surgeons’ response to market events and trends
- Pattern analysis of usage of PSG devices by physicians
- Surgeons’ opinion about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customer perception and behavior through our inbuilt social connect tool (digital marketing language) checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Competitive Intelligence
- Company share analysis of the key players forecasted till 2018 across sub-segments, country-wise
- Business strategies by key players to enhance the bottom line
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Polysomnography (PSG) Device, By Types
4.1 Split By Geography
4.1 Polysomnography (PSG) Device-Europe by Types
4.1 Polysomnography (PSG) Device-Asia by Types
4.1 Polysomnography (PSG) Device-Rest of World by Types
4.1 Polysomnography (PSG) Device-North America by Types
4.2 Clinical Polysomnography (PSG) Device
4.3 Ambulatory Polysomnography (PSG) Device
5 Polysomnography (PSG) Device, By Geographies
5.1 Polysomnography (PSG) Device-Europe
5.2 Polysomnography (PSG) Device-Asia
5.3 Polysomnography (PSG) Device-Rest of World
5.4 Polysomnography (PSG) Device-North America
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Polysomnography (PSG) Device The North American Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $1.3 billion in 2013 and is expected to reach a value of $2.5 billion in 2018, with a CAGR of 14.7% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report. |
Upcoming |
|
|
European Polysomnography (PSG) Device The European Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $526.2 million in 2013 and is expected to reach a value of $1.0 billion in 2018, with a CAGR of 14.2% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report. |
Upcoming |
|
|
Asian Polysomnography (PSG) Device The Asian Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $292.7 million in 2013 and is expected to reach a value of $611.3 million in 2018, with a CAGR of 15.9% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report. |
Upcoming |
